Humana Inc. (NYSE:HUM) Stock Now Rated “Hold” by Wall Street Brokerages

Shares of Humana Inc. (NYSE:HUM – Get Free Report) have been given a consensus recommendation of “Hold” by the thirty research firms that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and fifteen have issued a buy recommendation on the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $408.61.

Several analysts have weighed in on the company. TD Cowen boosted their price objective on Humana from $350.00 to $370.00 and gave the stock a “hold” rating in a report on Friday, July 31st. Piper Sandler upgraded shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 price target for the company in a research report on Thursday, July 30th. JPMorgan Chase & Co. boosted their price target on shares of Humana from $316.00 to $393.00 and gave the stock a “neutral” rating in a research note on Monday, August 10th. Zacks Research lowered shares of Humana from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Finally, Wells Fargo & Company raised shares of Humana from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $227.00 to $502.00 in a research note on Monday, July 13th.

Read Our Latest Report on HUM

Humana Stock Down 2.0%

Shares of NYSE:HUM opened at $389.91 on Tuesday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The firm has a market cap of $46.82 billion, a P/E ratio of 36.89, a P/E/G ratio of 2.46 and a beta of 0.74. Humana has a 12 month low of $163.11 and a 12 month high of $428.88. The company’s 50-day moving average price is $386.37 and its two-hundred day moving average price is $320.31.

Humana (NYSE:HUM – Get Free Report) last announced its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. The company had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company’s revenue was up 26.2% on a year-over-year basis. During the same period in the previous year, the firm posted $6.27 earnings per share. As a group, research analysts forecast that Humana will post 9 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Stockholders of record on Friday, October 30th will be paid a $0.8850 dividend. The ex-dividend date of this dividend is Friday, October 30th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. Humana’s dividend payout ratio is 33.49%.

Institutional Investors Weigh In On Humana

Institutional investors have recently made changes to their positions in the stock. QRG Capital Management Inc. boosted its holdings in Humana by 31.5% during the second quarter. QRG Capital Management Inc. now owns 3,025 shares of the insurance provider’s stock worth $1,202,000 after buying an additional 725 shares during the last quarter. Envestnet Asset Management Inc. increased its stake in shares of Humana by 180.2% in the 2nd quarter. Envestnet Asset Management Inc. now owns 38,820 shares of the insurance provider’s stock valued at $15,420,000 after acquiring an additional 24,964 shares during the last quarter. The Manufacturers Life Insurance Company increased its stake in shares of Humana by 10.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 70,185 shares of the insurance provider’s stock valued at $27,879,000 after acquiring an additional 6,690 shares during the last quarter. Sequoia Financial Advisors LLC raised its position in shares of Humana by 55.6% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 5,753 shares of the insurance provider’s stock valued at $2,285,000 after acquiring an additional 2,055 shares during the period. Finally, Tidal Investments LLC raised its position in shares of Humana by 24.5% in the 2nd quarter. Tidal Investments LLC now owns 470,587 shares of the insurance provider’s stock valued at $186,927,000 after acquiring an additional 92,496 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Company Profile

(Get Free Report)

Humana Inc is a health and well-being company headquartered in Louisville, Kentucky. Founded in 1961, the company began as a nursing home operator before expanding into hospitals and health insurance. Today, Humana primarily provides health insurance products and healthcare services for older adults, individuals, military families and other members in the United States.

Humana’s insurance business offers Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid coverage in select markets.

Featured Articles

Analyst Recommendations for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.